Cited by

• Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine.

  Luangdilok S, Wanchaijiraboon P, Pakvisal N, Susiriwatananont T, Zungsontiporn N, Sriuranpong V, Sainamthip P, Suntronwong N, Vichaiwattana P, Wanlapakorn N, Poovorawan Y, Teeyapun N, Tanasanvimon S. Luangdilok S, et al. Vaccines (Basel). 2022 Sep 26;10(10):1613. doi: 10.3390/vaccines10101613. Vaccines (Basel). 2022. PMID: 36298478 Free PMC article.
• A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants.

  Rabaan AA, Mutair AA, Hajissa K, Alfaraj AH, Al-Jishi JM, Alhajri M, Alwarthan S, Alsuliman SA, Al-Najjar AH, Al Zaydani IA, Al-Absi GH, Alshaikh SA, Alkathlan MS, Almuthree SA, Alawfi A, Alshengeti A, Almubarak FZ, Qashgari MS, Abdalla ANK, Alhumaid S. Rabaan AA, et al. Vaccines (Basel). 2022 Oct 2;10(10):1655. doi: 10.3390/vaccines10101655. Vaccines (Basel). 2022. PMID: 36298520 Free PMC article. Review.
• Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study.

  Gray KJ, Bordt EA, Atyeo C, Deriso E, Akinwunmi B, Young N, Baez AM, Shook LL, Cvrk D, James K, De Guzman R, Brigida S, Diouf K, Goldfarb I, Bebell LM, Yonker LM, Fasano A, Rabi SA, Elovitz MA, Alter G, Edlow AG. Gray KJ, et al. Am J Obstet Gynecol. 2021 Sep;225(3):303.e1-303.e17. doi: 10.1016/j.ajog.2021.03.023. Epub 2021 Mar 26. Am J Obstet Gynecol. 2021. PMID: 33775692 Free PMC article.
• Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern.

  Xie T, Lu S, He Z, Liu H, Wang J, Tang C, Yang T, Yu W, Li H, Yang Y, Yang H, Yue L, Zhou Y, Yang F, Luo Z, Li Y, Xiang H, Zhao Y, Wang J, Wang H, Long R, Kuang D, Tan W, Peng X, Li Q, Xie Z. Xie T, et al. Signal Transduct Target Ther. 2022 Feb 25;7(1):61. doi: 10.1038/s41392-022-00920-4. Signal Transduct Target Ther. 2022. PMID: 35217639 Free PMC article.
• The Outcome of BNT162b2, ChAdOx1-Sand mRNA-1273 Vaccines and Two Boosters: A Prospective Longitudinal Real-World Study.

  Kamal SM, Naghib MM, Daadour M, Alsuliman MN, Alanazi ZG, Basalem AA, Alaskar AM, Saed K. Kamal SM, et al. Viruses. 2023 Jan 24;15(2):326. doi: 10.3390/v15020326. Viruses. 2023. PMID: 36851540 Free PMC article.